Suppr超能文献

2 型糖尿病的肾脏结构:事实与误区。

Renal structure in type 2 diabetes: facts and misconceptions.

机构信息

Department of Medicine, Clinica Medica 3, University of Padova, Via Giustiniani 2, 35128, Padova, Italy.

Department of Pediatrics and Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA.

出版信息

J Nephrol. 2020 Oct;33(5):901-907. doi: 10.1007/s40620-020-00797-y. Epub 2020 Jul 12.

Abstract

The clinical manifestations of diabetic nephropathy are similar in type 1 and type 2 diabetes, while the renal lesions may differ. Indeed, diabetic glomerulopathy is the predominant renal lesion in type 1 diabetes, although also tubular, interstitial and arteriolar lesions are present in the advanced stages of renal disease. In contrast, in type 2 diabetes renal lesions are heterogeneous, and a substantial number of type 2 diabetic patients with diabetic kidney disease have mild or absent glomerulopathy with tubulointerstitial and/or arteriolar abnormalities. In addition, a high prevalence of non-diabetic renal diseases, isolated or superimposed on classic diabetic nephropathy lesions have been reported in patients with type 2 diabetes, often reflecting the bias of selecting patients for unusual clinical presentations for renal biopsy. This review focuses on renal structural changes in type 2 diabetes, emphasizing the contribution of research kidney biopsy studies to the understanding of the pathogenesis of DKD and of the structural lesions responsible for the different clinical phenotypes. Also, kidney biopsies could provide relevant information in terms of renal prognosis, and help to understand the different responses to different therapies, especially SGLT2 inhibitors, thus allowing personalized medicine.

摘要

糖尿病肾病的临床表现在 1 型和 2 型糖尿病中相似,而肾脏病变可能不同。实际上,在 1 型糖尿病中,糖尿病肾小球病变是主要的肾脏病变,尽管在肾脏病的晚期也存在肾小管、间质和小动脉病变。相比之下,在 2 型糖尿病中,肾脏病变是异质性的,并且相当数量的 2 型糖尿病伴糖尿病肾病患者的肾小球病变较轻或不存在,伴有肾小管间质和/或小动脉异常。此外,在 2 型糖尿病患者中,已经报道了非糖尿病性肾脏疾病的高发,这些疾病单独存在或叠加在经典的糖尿病肾病病变上,这通常反映了为肾脏活检选择不常见临床表现的患者的偏倚。这篇综述重点关注 2 型糖尿病的肾脏结构变化,强调研究性肾脏活检研究对理解 DKD 的发病机制以及导致不同临床表型的结构病变的贡献。此外,肾脏活检可以提供有关肾脏预后的相关信息,并有助于了解对不同治疗方法的不同反应,特别是 SGLT2 抑制剂,从而实现个体化治疗。

相似文献

1
Renal structure in type 2 diabetes: facts and misconceptions.2 型糖尿病的肾脏结构:事实与误区。
J Nephrol. 2020 Oct;33(5):901-907. doi: 10.1007/s40620-020-00797-y. Epub 2020 Jul 12.
2
Histopathology of diabetic nephropathy.糖尿病肾病的组织病理学
Semin Nephrol. 2007 Mar;27(2):195-207. doi: 10.1016/j.semnephrol.2007.01.012.

引用本文的文献

9
Kidney Considerations in Pediatric Obesity.儿科肥胖症中的肾脏问题。
Curr Obes Rep. 2023 Sep;12(3):332-344. doi: 10.1007/s13679-023-00522-3. Epub 2023 Aug 10.
10
Genetic and epigenetic background of diabetic kidney disease.糖尿病肾病的遗传和表观遗传背景。
Front Endocrinol (Lausanne). 2023 May 30;14:1163001. doi: 10.3389/fendo.2023.1163001. eCollection 2023.

本文引用的文献

3
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.达格列净与 2 型糖尿病患者的心血管结局
N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验